99 related articles for article (PubMed ID: 2178799)
1. Bone marrow failure after hemorrhagic shock.
Livingston DH; Gentile PS; Malangoni MA
Circ Shock; 1990 Mar; 30(3):255-63. PubMed ID: 2178799
[TBL] [Abstract][Full Text] [Related]
2. Hemorrhagic shock inhibits lipopolysaccharide-induced myelopoiesis in both germ-free and conventional rats.
Livingston DH; Wang MT; Hsieh J; Murphy TF; Rush BF
Surgery; 1992 Oct; 112(4):773-9; discussion 779-80. PubMed ID: 1411950
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic progenitor cells mobilize to the site of injury after trauma and hemorrhagic shock in rats.
Badami CD; Livingston DH; Sifri ZC; Caputo FJ; Bonilla L; Mohr AM; Deitch EA
J Trauma; 2007 Sep; 63(3):596-600; discussion 600-2. PubMed ID: 18073606
[TBL] [Abstract][Full Text] [Related]
4. Hemorrhagic shock abolishes the myelopoietic response to turpentine-induced soft tissue injury.
Raff G; Livingston DH; Wang MT; Rameshwar P
J Surg Res; 1995 Jul; 59(1):75-9. PubMed ID: 7630140
[TBL] [Abstract][Full Text] [Related]
5. Sex hormones affect bone marrow dysfunction after trauma and hemorrhagic shock.
Sifri ZC; Cohen D; Ananthakrishnan P; Wang L; Kaiser VL; Mohr AM; Hauser CJ; Rameshwar P; Deitch EA; Livingston DH
Crit Care Med; 2007 Mar; 35(3):864-9. PubMed ID: 17255869
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma reverses bone marrow inhibition following hemorrhagic shock.
Livingston DH
Arch Surg; 1991 Jan; 126(1):100-3. PubMed ID: 1898696
[TBL] [Abstract][Full Text] [Related]
7. Small volume albumin administration protects against hemorrhagic shock-induced bone marrow dysfunction.
Osband AJ; Sifri ZC; Wang L; Cohen D; Hauser CJ; Mohr AM; Deitch EA; Livingston DH
J Trauma; 2004 Feb; 56(2):279-83. PubMed ID: 14960968
[TBL] [Abstract][Full Text] [Related]
8. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
9. Mobilization of bone marrow cells to the site of injury is necessary for wound healing.
Shah S; Ulm J; Sifri ZC; Mohr AM; Livingston DH
J Trauma; 2009 Aug; 67(2):315-21; discussion 321-2. PubMed ID: 19667884
[TBL] [Abstract][Full Text] [Related]
10. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
[TBL] [Abstract][Full Text] [Related]
11. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
12. Sublethal hemorrhagic shock reduces tumor necrosis factor-alpha-producing capacity in different cell compartments.
Flohé S; Ackermann M; Reuter M; Nast-Kolb D; Schade FU
Eur Cytokine Netw; 2000 Sep; 11(3):420-6. PubMed ID: 11022127
[TBL] [Abstract][Full Text] [Related]
13. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
Slavin S; Mumcuoglu M; Landesberg-Weisz A; Kedar E
Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
15. Influence of IL-1 alpha and -1 beta on the survival of human bone marrow cells responding to hematopoietic colony-stimulating factors.
Hangoc G; Williams DE; Falkenburg JH; Broxmeyer HE
J Immunol; 1989 Jun; 142(12):4329-34. PubMed ID: 2656864
[TBL] [Abstract][Full Text] [Related]
16. Blockade of prostaglandin biosynthesis in intact mice dramatically augments the expansion of committed myeloid progenitor cells (colony-forming units-granulocyte, macrophage) after acute administration of recombinant human IL-1 alpha.
Pelus LM
J Immunol; 1989 Dec; 143(12):4171-9. PubMed ID: 2592770
[TBL] [Abstract][Full Text] [Related]
17. GM-CSF counteracts hemorrhage-induced suppression of cytokine-producing capacity.
Husain B; Lendemans S; Ackermann M; Wendel A; Schade FU; Flohé S
Inflamm Res; 2004 Jan; 53(1):13-21. PubMed ID: 15021976
[TBL] [Abstract][Full Text] [Related]
18. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
Mumcuoglu M; Naparstek E; Slavin S
Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
[TBL] [Abstract][Full Text] [Related]
19. Gut ischemia induces bone marrow failure and increases risk of infection.
Fontes B; Moore FA; Moore EE; Koike K; Kim F; Trew CE; Peterson VM
J Surg Res; 1994 Oct; 57(4):505-9. PubMed ID: 7934028
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow failure following severe injury in humans.
Livingston DH; Anjaria D; Wu J; Hauser CJ; Chang V; Deitch EA; Rameshwar P
Ann Surg; 2003 Nov; 238(5):748-53. PubMed ID: 14578739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
